Cargando…

Monoclonal Antibodies to Disrupt Progression of Early Covid-19 Infection

Detalles Bibliográficos
Autor principal:	Cohen, Myron S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844860/ https://www.ncbi.nlm.nih.gov/pubmed/33471984 http://dx.doi.org/10.1056/NEJMe2034495

Ejemplares similares

Monoclonal Antibodies with Extended Half-Life to Prevent Covid-19
por: Abraham, Jonathan
Publicado: (2022)

“Monoclonal-Type” Plastic Antibodies for COVID-19 Treatment: What Is the Idea?
por: Puoci, Francesco
Publicado: (2020)

Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence
por: Cohen, Myron S.
Publicado: (2020)

Special Issue: Monoclonal Antibodies
por: Klein, Christian
Publicado: (2018)

Early treatment to prevent progression of SARS-CoV-2 infection
por: Cohen, Myron S
Publicado: (2022)

Therapeutic Monoclonal Antibodies and Emergence of Their Biosimilars
por: Jeddi-Tehrani, Mahmood
Publicado: (2018)

Antibacterial Monoclonal Antibodies Do Not Disrupt the Intestinal Microbiome or Its Function
por: Jones-Nelson, Omari, et al.
Publicado: (2020)

Monoclonal Antibody a Promising Treatment for Depression
por: Akhondzadeh, Shahin
Publicado: (2019)

Neutralizing Monoclonal Antibody Use and COVID-19 Infection Outcomes
por: Ambrose, Nalini, et al.
Publicado: (2023)

Monoclonal Antibody for Reducing Memory and Learning Problems in Schizophrenia
por: Akhondzadeh, Shahin
Publicado: (2018)

Monoclonal antibodies as treatment for COVID-19
por: Medina Gamero, A., et al.
Publicado: (2022)

Editorial: Post-Exposure Prophylactic Neutralizing Monoclonal Antibodies to SARS-CoV-2 for Individuals at High Risk for COVID-19
por: Parums, Dinah V.
Publicado: (2021)

Advances in the progress of monoclonal antibodies for rabies
por: Fan, Linlin, et al.
Publicado: (2022)

Monoclonal Antibody Infusion Service for Obstetric Women Infected With COVID-19
por: Hiner, Jacqueline B., et al.
Publicado: (2022)

Monoclonal Antibody Disrupts Biofilm Structure and Restores Antibiotic Susceptibility in an Orthopedic Implant Infection Model
por: Burke, Zachary D. C., et al.
Publicado: (2023)

Human Monoclonal Antibodies as a New Class of Antiinfective Compounds
por: Burioni, Roberto, et al.
Publicado: (2013)

PCSK9 Inhibitors: What Lies Beyond Monoclonal Antibodies?
por: EBioMedicine
Publicado: (2015)

Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections
por: Mokhtary, Pardis, et al.
Publicado: (2022)

COVID-19 disruption: Family physicians at the forefront
por: Hugo, Johannes F.
Publicado: (2021)

Neutralizing monoclonal antibodies for treatment of COVID-19
por: Taylor, Peter C., et al.
Publicado: (2021)

Tackling COVID-19 with neutralizing monoclonal antibodies
por: Corti, Davide, et al.
Publicado: (2021)

Tackling COVID-19 with neutralizing monoclonal antibodies
por: Corti, Davide, et al.
Publicado: (2021)

The Relevance of Monoclonal Antibodies in the Treatment of COVID-19
por: Torrente-López, Anabel, et al.
Publicado: (2021)

Engineering monoclonal antibodies for COVID-19 prophylaxis
por: Izadpanah, Amin, et al.
Publicado: (2022)

Antiviral monoclonal antibody cocktails as a modern weapon in combating pandemics
por: Liu, Dingjiang, et al.
Publicado: (2021)

Monoclonal Antibodies against Epidermal Growth Factor Receptor in Solid Tumors
por: Saba, Nabil F., et al.
Publicado: (2012)

Comparative Efficacy of Early COVID-19 Monoclonal Antibody Therapies: A Retrospective Analysis
por: San Filippo, Savanna, et al.
Publicado: (2022)

549. Monoclonal Antibody Therapy for COVID-19 Infection in Michigan: The Flint Experience
por: Younas, Mariam, et al.
Publicado: (2021)

Editorial: Tocilizumab, a Humanized Therapeutic IL-6 Receptor (IL-6R) Monoclonal Antibody, and Future Combination Therapies for Severe COVID-19
por: Parums, Dinah V.
Publicado: (2021)

Decrypting the Crypt: Novel Monoclonal Antibodies to Identify Intestinal Stem Cell Populations
por: Sheahan, Breanna, et al.
Publicado: (2018)

Catching the evader: Can monoclonal antibodies interfere with Staphylococcus aureus immune escape?
por: Rasigade, Jean-Philippe
Publicado: (2017)

Recent advances in targeted therapy of colorectal cancer: impacts of monoclonal antibodies nanoconjugates
por: Akbarzadeh Khiavi, Mostafa, et al.
Publicado: (2019)

Neutralizing monoclonal antibodies for COVID-19 treatment and prevention
por: Jaworski, Juan Pablo
Publicado: (2021)

Administration of Monoclonal Antibody for COVID-19 in Patient Homes
por: Malani, Anurag N., et al.
Publicado: (2021)

Role of monoclonal antibody drugs in the treatment of COVID-19
por: Ucciferri, Claudio, et al.
Publicado: (2020)

Monoclonal antibody as a potential anti-COVID-19
por: Jahanshahlu, Leila, et al.
Publicado: (2020)

Monoclonal antibody levels and protection from COVID-19
por: Stadler, Eva, et al.
Publicado: (2023)

Real-world Effectiveness and Tolerability of Monoclonal Antibody Therapy for Ambulatory Patients With Early COVID-19
por: Webb, Brandon J, et al.
Publicado: (2021)

The Therapeutic Value of Monoclonal Antibodies Directed Against Immunogenic Tumor Glycoproteins
por: Arlen, Myron, et al.
Publicado: (2010)

Reactions and COVID-19 disease progression following SARS-CoV-2 monoclonal antibody infusion
por: Goldin, Laurel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hu6culjv70bbbal3vse38fnf5r